Soheila Korourian

High Impact

Professor

University of Arkansas for Medical Sciences

faculty

Pathology, College of Medicine

44 h-index 169 pubs 5,422 cited

Is this your profile? Verify and claim your profile

Biography and Research Information

OverviewAI-generated summary

Soheila Korourian's research focuses on the impact of diet, particularly soy protein, on metabolic conditions like non-alcoholic fatty liver disease (NAFLD). Her work investigates how dietary interventions, including those with varying levels of isoflavones, can reverse or protect against liver steatosis in obese animal models, such as Zucker rats. These studies also examine the effects of obesity and potential treatments like metformin on liver health.

Korourian's research extends to understanding how diet influences the gut microbial composition. Her recent publications demonstrate that dietary soy protein can alter gut microbiota independently of isoflavone content, suggesting a complex interplay between diet, gut health, and metabolic outcomes. She also has a publication related to educational topics in cytopathology fellowship training.

With a h-index of 44 and over 5,400 citations from 169 publications, Korourian is recognized as a highly cited researcher. She leads a research group and collaborates with researchers at the University of Arkansas for Medical Sciences, including Reza Hakkak and Elisabet Børsheim, as well as Nathan C. Twaddle from the National Center for Toxicological Research.

Metrics

  • h-index: 44
  • Publications: 169
  • Citations: 5,422

Selected Publications

  • Dietary soy protein reverses obesity-induced liver steatosis and alters fecal microbial composition independent of isoflavone level (2024) DOI
  • Entrustable professional activities for cytopathology fellowship (2024) DOI
  • Soy Protein Concentrate With Low and High Isoflavones Can Reverse Non-alcoholic Fatty Liver Disease Caused by Obesity and Alter Gut Microbial Composition (2024) DOI
  • Long-Term Feeding Soy Protein Concentrates Protect Against Hepatic Steatosis Independent of Isoflavone Levels (2023) DOI
  • Diet Containing Soy Protein Concentrate With Low and High Isoflavones for 9 Weeks Protects Against Non-alcoholic Fatty Liver Steatosis Using Obese Zucker Rats (2022) DOI
  • Abstract 740: Obesity promotes liver pro-oxidative and DNA damage in mammary tumor of Zucker rats (2022) DOI
  • Effects of 8 Weeks Feeding Diet with Low and High Isoflavones Soy Protein Concentrate on Serum Isoflavones in Non-alcoholic Fatty Liver Disease (NAFLD) Rat Model (2022) DOI
  • Diet Containing Soy Protein Concentrate with Low and High Isoflavones for 18 Weeks Protects Against Non-alcoholic Fatty Liver Diseases (2022) DOI
  • Effects of Obesity and Low and High Isoflavones in Soy Protein Concentrate Diet on Liver Steatosis (2021) DOI
  • Effects of obesity and 10 weeks metformin treatment on liver steatosis (2021) DOI

Collaborators

Researchers in the database who share publications

Similar Researchers

Based on overlapping research topics